Copyright Reports & Markets. All rights reserved.

Global Veterinary Prostaglandin Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Veterinary Prostaglandin Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Cloprostenol
    • 1.3.3 D-Cloprostenol
    • 1.3.4 D-Cloprostenol Sodium
    • 1.3.5 DL-Cloprostenol Sodium
    • 1.3.6 Fluprostenol
    • 1.3.7 D-Fluprostenol/ Travoprost Acid
    • 1.3.8 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Veterinary Prostaglandin Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Cardiovascular
    • 1.4.3 Gynecological and Obstetrical
    • 1.4.4 Ophthalmologic
    • 1.4.5 Others
  • 1.5 Global Veterinary Prostaglandin Market Size & Forecast
    • 1.5.1 Global Veterinary Prostaglandin Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Veterinary Prostaglandin Sales Quantity (2021-2032)
    • 1.5.3 Global Veterinary Prostaglandin Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Sanofi CEPiA
    • 2.1.1 Sanofi CEPiA Details
    • 2.1.2 Sanofi CEPiA Major Business
    • 2.1.3 Sanofi CEPiA Veterinary Prostaglandin Product and Services
    • 2.1.4 Sanofi CEPiA Veterinary Prostaglandin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Sanofi CEPiA Recent Developments/Updates
  • 2.2 Kyowa Hakko Pharma
    • 2.2.1 Kyowa Hakko Pharma Details
    • 2.2.2 Kyowa Hakko Pharma Major Business
    • 2.2.3 Kyowa Hakko Pharma Veterinary Prostaglandin Product and Services
    • 2.2.4 Kyowa Hakko Pharma Veterinary Prostaglandin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Kyowa Hakko Pharma Recent Developments/Updates
  • 2.3 Cayman Chemical
    • 2.3.1 Cayman Chemical Details
    • 2.3.2 Cayman Chemical Major Business
    • 2.3.3 Cayman Chemical Veterinary Prostaglandin Product and Services
    • 2.3.4 Cayman Chemical Veterinary Prostaglandin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Cayman Chemical Recent Developments/Updates
  • 2.4 Yonsung Fine Chemicals
    • 2.4.1 Yonsung Fine Chemicals Details
    • 2.4.2 Yonsung Fine Chemicals Major Business
    • 2.4.3 Yonsung Fine Chemicals Veterinary Prostaglandin Product and Services
    • 2.4.4 Yonsung Fine Chemicals Veterinary Prostaglandin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Yonsung Fine Chemicals Recent Developments/Updates
  • 2.5 Johnson Matthey
    • 2.5.1 Johnson Matthey Details
    • 2.5.2 Johnson Matthey Major Business
    • 2.5.3 Johnson Matthey Veterinary Prostaglandin Product and Services
    • 2.5.4 Johnson Matthey Veterinary Prostaglandin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Johnson Matthey Recent Developments/Updates
  • 2.6 Chirogate
    • 2.6.1 Chirogate Details
    • 2.6.2 Chirogate Major Business
    • 2.6.3 Chirogate Veterinary Prostaglandin Product and Services
    • 2.6.4 Chirogate Veterinary Prostaglandin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Chirogate Recent Developments/Updates
  • 2.7 Everlight Chemical
    • 2.7.1 Everlight Chemical Details
    • 2.7.2 Everlight Chemical Major Business
    • 2.7.3 Everlight Chemical Veterinary Prostaglandin Product and Services
    • 2.7.4 Everlight Chemical Veterinary Prostaglandin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Everlight Chemical Recent Developments/Updates
  • 2.8 ANVI Pharma
    • 2.8.1 ANVI Pharma Details
    • 2.8.2 ANVI Pharma Major Business
    • 2.8.3 ANVI Pharma Veterinary Prostaglandin Product and Services
    • 2.8.4 ANVI Pharma Veterinary Prostaglandin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 ANVI Pharma Recent Developments/Updates
  • 2.9 AUSUN Pharmaceutical
    • 2.9.1 AUSUN Pharmaceutical Details
    • 2.9.2 AUSUN Pharmaceutical Major Business
    • 2.9.3 AUSUN Pharmaceutical Veterinary Prostaglandin Product and Services
    • 2.9.4 AUSUN Pharmaceutical Veterinary Prostaglandin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 AUSUN Pharmaceutical Recent Developments/Updates
  • 2.10 Aspen Biopharma Labs
    • 2.10.1 Aspen Biopharma Labs Details
    • 2.10.2 Aspen Biopharma Labs Major Business
    • 2.10.3 Aspen Biopharma Labs Veterinary Prostaglandin Product and Services
    • 2.10.4 Aspen Biopharma Labs Veterinary Prostaglandin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Aspen Biopharma Labs Recent Developments/Updates

3 Competitive Environment: Veterinary Prostaglandin by Manufacturer

  • 3.1 Global Veterinary Prostaglandin Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Veterinary Prostaglandin Revenue by Manufacturer (2021-2026)
  • 3.3 Global Veterinary Prostaglandin Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Veterinary Prostaglandin by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Veterinary Prostaglandin Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Veterinary Prostaglandin Manufacturer Market Share in 2025
  • 3.5 Veterinary Prostaglandin Market: Overall Company Footprint Analysis
    • 3.5.1 Veterinary Prostaglandin Market: Region Footprint
    • 3.5.2 Veterinary Prostaglandin Market: Company Product Type Footprint
    • 3.5.3 Veterinary Prostaglandin Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Veterinary Prostaglandin Market Size by Region
    • 4.1.1 Global Veterinary Prostaglandin Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Veterinary Prostaglandin Consumption Value by Region (2021-2032)
    • 4.1.3 Global Veterinary Prostaglandin Average Price by Region (2021-2032)
  • 4.2 North America Veterinary Prostaglandin Consumption Value (2021-2032)
  • 4.3 Europe Veterinary Prostaglandin Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Veterinary Prostaglandin Consumption Value (2021-2032)
  • 4.5 South America Veterinary Prostaglandin Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Veterinary Prostaglandin Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Veterinary Prostaglandin Sales Quantity by Type (2021-2032)
  • 5.2 Global Veterinary Prostaglandin Consumption Value by Type (2021-2032)
  • 5.3 Global Veterinary Prostaglandin Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Veterinary Prostaglandin Sales Quantity by Application (2021-2032)
  • 6.2 Global Veterinary Prostaglandin Consumption Value by Application (2021-2032)
  • 6.3 Global Veterinary Prostaglandin Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Veterinary Prostaglandin Sales Quantity by Type (2021-2032)
  • 7.2 North America Veterinary Prostaglandin Sales Quantity by Application (2021-2032)
  • 7.3 North America Veterinary Prostaglandin Market Size by Country
    • 7.3.1 North America Veterinary Prostaglandin Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Veterinary Prostaglandin Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Veterinary Prostaglandin Sales Quantity by Type (2021-2032)
  • 8.2 Europe Veterinary Prostaglandin Sales Quantity by Application (2021-2032)
  • 8.3 Europe Veterinary Prostaglandin Market Size by Country
    • 8.3.1 Europe Veterinary Prostaglandin Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Veterinary Prostaglandin Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Veterinary Prostaglandin Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Veterinary Prostaglandin Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Veterinary Prostaglandin Market Size by Region
    • 9.3.1 Asia-Pacific Veterinary Prostaglandin Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Veterinary Prostaglandin Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Veterinary Prostaglandin Sales Quantity by Type (2021-2032)
  • 10.2 South America Veterinary Prostaglandin Sales Quantity by Application (2021-2032)
  • 10.3 South America Veterinary Prostaglandin Market Size by Country
    • 10.3.1 South America Veterinary Prostaglandin Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Veterinary Prostaglandin Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Veterinary Prostaglandin Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Veterinary Prostaglandin Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Veterinary Prostaglandin Market Size by Country
    • 11.3.1 Middle East & Africa Veterinary Prostaglandin Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Veterinary Prostaglandin Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Veterinary Prostaglandin Market Drivers
  • 12.2 Veterinary Prostaglandin Market Restraints
  • 12.3 Veterinary Prostaglandin Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Veterinary Prostaglandin and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Veterinary Prostaglandin
  • 13.3 Veterinary Prostaglandin Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Veterinary Prostaglandin Typical Distributors
  • 14.3 Veterinary Prostaglandin Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Veterinary Prostaglandin market size was valued at US$ 56.85 million in 2025 and is forecast to a readjusted size of US$ 82.19 million by 2032 with a CAGR of 5.5% during review period.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Veterinary Prostaglandin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Veterinary Prostaglandin market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Veterinary Prostaglandin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Veterinary Prostaglandin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Veterinary Prostaglandin market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Veterinary Prostaglandin
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Veterinary Prostaglandin market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi CEPiA, Kyowa Hakko Pharma, Cayman Chemical, Yonsung Fine Chemicals, Johnson Matthey, Chirogate, Everlight Chemical, ANVI Pharma, AUSUN Pharmaceutical, Aspen Biopharma Labs, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Veterinary Prostaglandin market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Cloprostenol
    D-Cloprostenol
    D-Cloprostenol Sodium
    DL-Cloprostenol Sodium
    Fluprostenol
    D-Fluprostenol/ Travoprost Acid
    Others
    Market segment by Application
    Cardiovascular
    Gynecological and Obstetrical
    Ophthalmologic
    Others
    Major players covered
    Sanofi CEPiA
    Kyowa Hakko Pharma
    Cayman Chemical
    Yonsung Fine Chemicals
    Johnson Matthey
    Chirogate
    Everlight Chemical
    ANVI Pharma
    AUSUN Pharmaceutical
    Aspen Biopharma Labs
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Veterinary Prostaglandin product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Veterinary Prostaglandin, with price, sales quantity, revenue, and global market share of Veterinary Prostaglandin from 2021 to 2026.
    Chapter 3, the Veterinary Prostaglandin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Veterinary Prostaglandin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Veterinary Prostaglandin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Veterinary Prostaglandin.
    Chapter 14 and 15, to describe Veterinary Prostaglandin sales channel, distributors, customers, research findings and conclusion.

    Buy now